108 related articles for article (PubMed ID: 8962295)
21. Thrombotic microangiopathy in the early post-renal transplant period.
Ardalan MR; Shoja MM; Tubbs RS; Etemadi J; Esmaili H; Khosroshahi HT
Ren Fail; 2008; 30(2):199-203. PubMed ID: 18300121
[TBL] [Abstract][Full Text] [Related]
22. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
Bandur S; Petrasek J; Hribova P; Novotna E; Brabcova I; Viklicky O
Transplantation; 2008 Nov; 86(9):1206-13. PubMed ID: 19005401
[TBL] [Abstract][Full Text] [Related]
23. [Characteristics of neoplasm occurrence of renal allograft recipients and their prognosis].
Wang CX; Liu LS; Chen LZ; Wu PG; Xie D; Fei JG; Qiu J; Deng SX; Zheng KL; Ji YL; Zhu LY; Shen QR; He XS
Ai Zheng; 2005 Feb; 24(2):222-5. PubMed ID: 15694039
[TBL] [Abstract][Full Text] [Related]
24. Reduced graft function (with or without dialysis) vs immediate graft function--a comparison of long-term renal allograft survival.
Johnston O; O'kelly P; Spencer S; Donohoe J; Walshe JJ; Little DM; Hickey D; Conlon PJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2270-4. PubMed ID: 16720598
[TBL] [Abstract][Full Text] [Related]
25. [Ways of reducing mortality in emergency abdominal surgery].
Maiat VS
Sov Med; 1984; (4):3-6. PubMed ID: 6740396
[No Abstract] [Full Text] [Related]
26. Tuberculosis in renal allograft recipients.
Koselj M; Buturovic J; Malovrh M
Transplant Proc; 1992 Oct; 24(5):1909-10. PubMed ID: 1412907
[No Abstract] [Full Text] [Related]
27. [Acute abdomen in the elderly].
Jekić ML; Jekić IM
Helv Chir Acta; 1994 Apr; 60(4):495-7. PubMed ID: 8034524
[TBL] [Abstract][Full Text] [Related]
28. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
29. Low incidence of adverse events in outpatient pediatric renal allograft biopsies.
Birk PE; Blydt-Hansen TD; Dart AB; Kaita LM; Proulx C; Taylor G
Pediatr Transplant; 2007 Mar; 11(2):196-200. PubMed ID: 17300500
[TBL] [Abstract][Full Text] [Related]
30. [The causes of complications and mortality in acute diseases of the abdominal organs].
Slepykh NI
Vestn Khir Im I I Grek; 2000; 159(2):39-43. PubMed ID: 10890067
[TBL] [Abstract][Full Text] [Related]
31. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
32. [The abdominal emergency after heart surgery interventions].
Wolken D; Hellberg K; Thon KP
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():988-90. PubMed ID: 9931768
[TBL] [Abstract][Full Text] [Related]
33. Results of renal transplantation at the Gdańsk Center.
Zdrojewski Z; Rutkowski B; Lichodziejewska-Niemierko M; Debska-Slizień A; Bułło B; Gacyk W; Pirski MI; Zadrozny D; Moszkowska G
Transplant Proc; 1996 Dec; 28(6):3492-3. PubMed ID: 8962358
[No Abstract] [Full Text] [Related]
34. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
35. Nephron-sparing surgery for renal tumor: a choice of treatment in an allograft kidney.
Ribal MJ; Rodriguez F; Musquera M; Segarra J; Guirado L; Villavicencio H; Alcaraz A
Transplant Proc; 2006 Jun; 38(5):1359-62. PubMed ID: 16797303
[TBL] [Abstract][Full Text] [Related]
36. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
[TBL] [Abstract][Full Text] [Related]
37. 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients.
Uyar M; Sezer S; Arat Z; Elsurer R; Ozdemir FN; Haberal M
Transplant Proc; 2006 Sep; 38(7):2069-73. PubMed ID: 16980002
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
39. Varicella infection in adult renal allograft recipients: experience at one center.
Rodriguez-Moreno A; Sanchez-Fructuoso AI; Calvo N; Ridao N; Conesa J; Marques M; Prats D; Barrientos A
Transplant Proc; 2006 Oct; 38(8):2416-8. PubMed ID: 17097954
[TBL] [Abstract][Full Text] [Related]
40. Infective complications in renal allograft recipients: epidemiology and outcome.
Veroux M; Giuffrida G; Corona D; Gagliano M; Scriffignano V; Vizcarra D; Tallarita T; Zerbo D; Virgilio C; Sciacca A; Cappello D; Stefani S; Veroux P
Transplant Proc; 2008; 40(6):1873-6. PubMed ID: 18675076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
